Financials

  • Market Capitalization 22.43 M
  • Employee 8
  • Founded 2021
  • CEO N/A
  • Website www.allarity.com
  • Headquarter Delaware, United States
  • FIGI BBG012NXCZP8
  • Industry Biotechnology
Total revenue
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents
Price to earnings ratio
-1.38
Price to sales ratio
48.53

Related tickers

#NamePrice24h %7d %1M %1Y %Market CapLast 7 Days
4522
JSPR
Jasper Therapeutics, Inc. - Class A Common Stock
0.70 USD0.00%0.00%+16.67%-74.73%23.29 M USD
4527
MRKR
Marker Therapeutics, Inc. - Common Stock
1.37 USD-6.16%-4.86%+23.42%+52.22%22.84 M USD
4535
DYAI
Dyadic International, Inc. - Common Stock
0.61 USD-4.69%-14.08%-42.99%-32.97%22.23 M USD
4538
ABVC
ABVC BioPharma, Inc. - Common Stock
0.83 USD+3.75%-6.74%-17.82%-70.67%22.12 M USD

Frequently asked questions about Allarity Therapeutics, Inc. Common Stock

What is the Allarity Therapeutics, Inc. Common Stock stock price today?

The current price of Allarity Therapeutics, Inc. Common Stock (ALLR) is 1.41. Over the past 24 hours, the stock has changed by +2.17%. Follow the ALLR chart for real-time price dynamics.

What is the stock ticker of Allarity Therapeutics, Inc. Common Stock?

Allarity Therapeutics, Inc. Common Stock trades under the ticker ALLR. Tickers can differ by exchange, so always check the exchange and instrument details before trading.

Is Allarity Therapeutics, Inc. Common Stock stock going up?

ALLR has changed by -0.70% over the last week, +17.50% over the last month, and -8.44% over the last year. Review the chart to see whether the current move is part of a broader trend.

What is the market capitalization of Allarity Therapeutics, Inc. Common Stock?

Allarity Therapeutics, Inc. Common Stock currently has a market capitalization of 22.43 M. Market capitalization reflects the total market value of a company's outstanding shares and is commonly used to compare companies by size.

What were Allarity Therapeutics, Inc. Common Stock earnings last quarter?

Last quarter, Allarity Therapeutics, Inc. Common Stock reported earnings of -0.21 per share. Earnings per share is one of the key metrics investors use to evaluate a company's profitability and financial performance.

What was Allarity Therapeutics, Inc. Common Stock revenue for the last quarter?

Allarity Therapeutics, Inc. Common Stock reported quarterly revenue of 0. Revenue is one of the main indicators used to evaluate the company's business growth and operating scale.

What was Allarity Therapeutics, Inc. Common Stock net income for the last quarter?

Allarity Therapeutics, Inc. Common Stock reported net income of -3.4 M for the last quarter. The previous quarter showed -2.75 M, which means net income changed by -23.82%.

How many employees does Allarity Therapeutics, Inc. Common Stock have?

As of the latest available data, Allarity Therapeutics, Inc. Common Stock has 8 employees. Workforce size can provide additional context about the company's scale and operations.

How can I buy Allarity Therapeutics, Inc. Common Stock stock?

You can buy Allarity Therapeutics, Inc. Common Stock (ALLR) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.

Should I invest in Allarity Therapeutics, Inc. Common Stock stock?

Investing in Allarity Therapeutics, Inc. Common Stock requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the ALLR chart and related analysis on metatrader.com as part of your research.

News